Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.99 - $3.85 $602,587 - $1.17 Million
-302,808 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$3.5 - $8.79 $7,238 - $18,177
-2,068 Reduced 0.68%
302,808 $1.08 Million
Q2 2021

Aug 16, 2021

SELL
$11.8 - $17.87 $918,488 - $1.39 Million
-77,838 Reduced 20.34%
304,876 $4.13 Million
Q1 2021

May 14, 2021

BUY
$17.0 - $29.99 $6.51 Million - $11.5 Million
382,714 New
382,714 $6.87 Million

Others Institutions Holding ADAG

About Adagene Inc.


  • Ticker ADAG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,423,200
  • Market Cap $81.6M
  • Description
  • Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...
More about ADAG
Track This Portfolio

Track Capital International, Inc. Portfolio

Follow Capital International, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.